Literature DB >> 10760057

Mineralocorticoid receptor knockout mice: lessons on Na+ metabolism.

S Berger1, M Bleich, W Schmid, R Greger, G Schütz.   

Abstract

The mineralocorticoid receptor (MR) binds aldosterone and glucocorticoids with equal affinity. In aldosterone target tissues, like the epithelial cells of the distal colon and the principal cells of the collecting ducts in the kidney, the MR is protected from glucocorticoids by the action of the enzyme 11beta-hydroxysteroid-dehydrogenase type 2 (11betaOHSD2), allowing aldosterone to specifically activate the receptor. However, in MR-expressing cells, which lack 11betaOHSD2, like the neurons of the limbic system in the brain, MR is mainly activated by glucocorticoids. MR knockout mice die in the second week after birth, showing at day 8 symptoms of pseudohypoaldosteronism with hyponatremia, hyperkalemia, high renal salt wasting, and a strongly activated renin-angiotensin-aldosterone system (RAAS). The activity of the amiloride-sensitive epithelial Na+ channel (ENaC) is strongly reduced in colon and kidney, but there is no down-regulation of the mRNA abundance of the three ENaC subunits. Daily subcutaneous injections of isotonic NaCl solution until weaning and continued oral NaCl supply lead to survival of the MR knockout mice. The NaCl-rescued MR knockout mice display a strongly enhanced fractional renal excretion of Na+, hyperkalemia, and a persistently strongly activated RAAS. There is almost no renal ENaC activity. The renal mRNA abundance of alphaENaC is reduced by 30%, whereas betaENaC and gammaENaC are not altered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760057     DOI: 10.1046/j.1523-1755.2000.00965.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  22 in total

1.  Expression and role of serum and glucocorticoid-regulated kinase 2 in the regulation of Na+/H+ exchanger 3 in the mammalian kidney.

Authors:  Alan C Pao; Aditi Bhargava; Francesca Di Sole; Raymond Quigley; Xinli Shao; Jian Wang; Sheela Thomas; Jianning Zhang; Mingjun Shi; John W Funder; Orson W Moe; David Pearce
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-06

Review 2.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

3.  Mineralocorticoid receptor antagonizes Dot1a-Af9 complex to increase αENaC transcription.

Authors:  Xi Zhang; Qiaoling Zhou; Lihe Chen; Stefan Berger; Hongyu Wu; Zhou Xiao; David Pearce; Xiaodong Zhou; Wenzheng Zhang
Journal:  Am J Physiol Renal Physiol       Date:  2013-09-11

Review 4.  The role of ENaC in vascular endothelium.

Authors:  Kristina Kusche-Vihrog; Pia Jeggle; Hans Oberleithner
Journal:  Pflugers Arch       Date:  2013-09-18       Impact factor: 3.657

Review 5.  Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?

Authors:  Elise P Gomez-Sanchez
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

6.  A role for mineralocorticoid receptors in the physiology of the ovine fetus: effects on ACTH and lung liquid composition.

Authors:  Maureen Keller-Wood; Charles E Wood; Jarret McCartney; Nathan M Jesse; Dana Perrone
Journal:  Pediatr Res       Date:  2011-06       Impact factor: 3.756

7.  The mineralocorticoid receptor (MR) regulates ENaC but not NCC in mice with random MR deletion.

Authors:  Jan Czogalla; Twinkle Vohra; David Penton; Moritz Kirschmann; Eilidh Craigie; Johannes Loffing
Journal:  Pflugers Arch       Date:  2016-02-22       Impact factor: 3.657

Review 8.  Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications.

Authors:  Adam P McGraw; Amy McCurley; Ioana R Preston; Iris Z Jaffe
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

Review 9.  Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.

Authors:  Kathleen V Barrett; Amy T McCurley; Iris Z Jaffe
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-12       Impact factor: 2.557

10.  Differential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney disease.

Authors:  Paula-Anahi Arias-Loza; Melanie Muehlfelder; Susan A Elmore; Robert Maronpot; Kai Hu; Hartmut Blode; Christa Hegele-Hartung; Karl Heinrich Fritzemeier; Georg Ertl; Theo Pelzer
Journal:  Toxicol Pathol       Date:  2009-12       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.